The primary goal of the Developmental Core of the Harvard University CFAR (HU CFAR) is to promote basic, clinical, behavioral and translational HIV/AIDS research activities at Harvard University. The Developmental Core provides the infrastructure through which short-term research proposals from individual and collaborating investigators are solicited, reviewed, and funded. The Developmental Core, through its funding mechanisms, also promotes HIV research collaboration across Harvard University, and facilitates the development of new experimental approaches in HU CFAR priority areas as defined by our Annual Strategic Planning Meeting. Through funding of Scholar awards and prioritizing funding of investigators without prior R01-type funding, the Developmental Core fosters career development of junior HIV researchers. In addition, by encouraging submissions from more established investigators who have not previously focused on AIDS research, the Developmental Core has an even broader impact on HIV research.
Specific Aims of the Developmental Core include: 1. To promote basic, clinical, behavioral and translational HIV/AIDS research activities at Harvard University, by providing the infrastructure through which short-term research proposals from individual and collaborating investigators are solicited, reviewed, and funded. 2. To promote multidisciplinary HIV research, and research collaboration across different institutions/schools at Harvard University, and with international colleagues. 3. To foster the career development of junior HIV researchers, through funding of Scholar awards and prioritizing funding of investigators without prior ROI-type funding, and through a mentoring program that provides guidance on grantsmanship and biostatistics/bioinformatics to junior investigators. 4. To facilitate the development of new experimental approaches in high priority, high risk research areas as directed by the Scientific Working Groups
With a focus on supporting junior faculty, the overarching goal of the Developmental Core is to promote the research priorities of the HU CFAR as outlined by the aims of the Scientific Programs and Scientific Working Groups by supporting multidisciplinary research in the prevention, detection, and treatment of HIV/AIDS in areas of basic, clinical, epidemiological, behavioral, and translational research.
|Hyle, Emily P; Mayosi, Bongani M; Middelkoop, Keren et al. (2017) The association between HIV and atherosclerotic cardiovascular disease in sub-Saharan Africa: a systematic review. BMC Public Health 17:954|
|Luckow, Peter W; Kenny, Avi; White, Emily et al. (2017) Implementation research on community health workers' provision of maternal and child health services in rural Liberia. Bull World Health Organ 95:113-120|
|McCluskey, Suzanne M; Boum 2nd, Yap; Musinguzi, Nicholas et al. (2017) Brief Report: Appraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure. J Acquir Immune Defic Syndr 76:183-187|
|Viganò, Selena; Negrón, Jordi J; Tse, Samantha et al. (2017) HLA-G+ HIV-1-specific CD8+ T cells are associated with HIV-1 immune control. AIDS 31:207-212|
|Brown, Danielle N; Langan, Sinéad M; Freeman, Esther E (2017) Task Shifting in Dermatology: A Call to Action. JAMA Dermatol 153:1179-1180|
|Calabrese, Sarah K; Underhill, Kristen; Mayer, Kenneth H (2017) HIV Preexposure Prophylaxis and Condomless Sex: Disentangling Personal Values From Public Health Priorities. Am J Public Health 107:1572-1576|
|Janjua, Sumbal A; Staziaki, Pedro V; Szilveszter, Balint et al. (2017) Presence, Characteristics, and Prognostic Associations of Carotid Plaque Among People Living With HIV. Circ Cardiovasc Imaging 10:|
|Manickam, Cordelia; Martinot, Amanda J; Jones, Rhianna A et al. (2017) Hepatic immunopathology during occult hepacivirus re-infection. Virology 512:48-55|
|Levison, Julie H; Bogart, Laura M; Khan, Iman F et al. (2017) ""Where It Falls Apart"": Barriers to Retention in HIV Care in Latino Immigrants and Migrants. AIDS Patient Care STDS 31:394-405|
|Mayer, Kenneth H; Jones, Daniel; Oldenburg, Catherine et al. (2017) Optimal HIV Postexposure Prophylaxis Regimen Completion With Single Tablet Daily Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine Compared With More Frequent Dosing Regimens. J Acquir Immune Defic Syndr 75:535-539|
Showing the most recent 10 out of 944 publications